A 52-year-old man with a 10-year history of essential hypertension on atenolol and hydrochlorothiazide presents with recent-onset hypokalemia (K⁺ 3.1 mEq/L), metabolic alkalosis, and hypertension (BP 168/104 mmHg) refractory to current therapy. Plasma renin activity is suppressed and plasma aldosterone is elevated. Which investigation is most appropriate to localize the source of primary aldosteronism?

Explanation

## Investigation of Choice for Localizing Primary Aldosteronism ### Clinical Context The patient presents with: - **Resistant hypertension** (BP 168/104 on dual therapy) - **Hypokalemia** (K⁺ 3.1 mEq/L) - **Metabolic alkalosis** (classic for aldosterone excess) - **Suppressed plasma renin activity** with **elevated plasma aldosterone** (diagnostic of primary aldosteronism) The next step is **localization** — determining whether the source is an **aldosterone-producing adenoma (APA)** or **idiopathic hyperaldosteronism (IHA)**. ### Why Adrenal Vein Sampling is the Gold Standard for Localization **Key Point:** Adrenal vein sampling (AVS) is the **gold standard** for lateralizing primary aldosteronism and distinguishing unilateral (APA) from bilateral (IHA) disease. | Investigation | Sensitivity | Specificity | Advantages | Limitations | |---|---|---|---|---| | **Adrenal vein sampling** | 95–100% | 95–100% | Gold standard for lateralization, guides surgical decision, invasive confirmation | Invasive, technically demanding, requires expertise, not universally available | | High-resolution CT | 70–80% | 60–70% | Non-invasive, widely available, detects adenomas > 1 cm | Poor sensitivity for small adenomas, cannot assess function, 10–15% of APAs are < 1 cm | | MRI with chemical shift | 75–85% | 65–75% | Non-invasive, good for characterizing adrenal lesions | Cannot reliably lateralize, poor functional assessment | | I-131 adrenolabeled scintigraphy | 60–80% | 50–70% | Functional imaging | Poor spatial resolution, rarely used, low specificity, radiation exposure | ### High-Yield Points **Key Point:** AVS is indicated when: 1. **Primary aldosteronism is confirmed** (suppressed PRA, elevated PAC) 2. **Surgery is being considered** (to confirm unilateral disease and predict outcome) 3. **Imaging is inconclusive** or shows bilateral lesions **Clinical Pearl:** In primary aldosteronism, **AVS with ACTH stimulation** improves accuracy by: - Reducing overlap between normal and abnormal veins - Increasing aldosterone secretion from the APA - Reducing aldosterone from the contralateral gland - **Selectivity index** (adrenal vein aldosterone / IVC aldosterone) confirms adequate sampling - **Lateralization ratio** (high-side aldosterone / low-side aldosterone) > 4:1 indicates unilateral disease (APA) **Mnemonic: AVS Indications — "DECIDE"** - **D**iagnosis confirmed (suppressed PRA, elevated PAC) - **E**xplore for unilateral vs. bilateral disease - **C**onsider surgery (need to know laterality) - **I**maging inconclusive or bilateral adenomas - **D**etermine candidacy for adrenalectomy - **E**nsure technical adequacy (selectivity index) ### Why Other Options Are Not First-Line for Localization 1. **High-resolution CT** — Good for detecting adenomas > 1 cm, but sensitivity is only 70–80%. Many APAs are < 1 cm and will be missed. Cannot assess **functional laterality**. Should be done first to rule out large lesions, but AVS is needed for definitive localization. 2. **MRI with chemical shift imaging** — Useful for characterizing adrenal lesions (lipid-rich adenomas show signal dropout), but cannot reliably **lateralize** aldosterone secretion. Sensitivity similar to CT (~75–85%), but lacks functional information. 3. **I-131 adrenolabeled scintigraphy** — Provides functional imaging but has poor spatial resolution and specificity (~50–70%). Rarely used in modern practice due to superior alternatives and radiation exposure. Largely historical. ### Clinical Decision Algorithm ```mermaid flowchart TD A[Primary aldosteronism confirmed<br/>suppressed PRA, elevated PAC]:::outcome --> B{Surgery being considered?}:::decision B -->|No| C[Medical management<br/>spironolactone/eplerenone]:::action B -->|Yes| D[Imaging: High-res CT<br/>or MRI]:::action D --> E{Unilateral adenoma<br/>on imaging?}:::decision E -->|Yes, clear| F[Consider AVS for confirmation<br/>before surgery]:::action E -->|No or bilateral| G[Adrenal vein sampling<br/>ACTH-stimulated]:::action G --> H{Lateralization ratio<br/>≥ 4:1?}:::decision H -->|Yes| I[Unilateral APA<br/>Adrenalectomy candidate]:::outcome H -->|No| J[Bilateral IHA<br/>Medical management]:::outcome ``` [cite:Harrison 21e Ch 297]